Symposium Program/Agenda
The times in the tables below are USA Eastern Time. The following is provided to help you convert it into your location time.
Paris, France: +6 hours
New Delhi, India: +10.5 hours
Beijing, China: +13 hours
Seoul, Korea: + 14 hours
Click here for a time conversion tool.
Due to the generosity of our sponsors, this is a free event.
Schedule updated: December 1, 2020, 10:59 PM CT, Chicago, IL
Saturday, December 5, 2020
Sunday, December 6, 2020
| Start-End (USA ET) | Session Title | Presenters |
|---|---|---|
| 6:00 AM – 7:00 AM | Poster session: Attendees will go on their own to view and chat with presenters on the iPosters website. | N/A |
| 7:00 AM – 7:30 AM | Virtual Waiting Room Opens | N/A |
| 7:30 AM – 7:40 AM | Welcome Message from Chairs | Davinder Parsad, MD & Iltefat Hamzavi, MD VIS 2020 Co-Chairs |
| 7:40 AM – 8:00 AM | Genetic and Environmental Correlates of Vitiligo | Invited Speaker: Richard A. Spritz, MD |
| 8:00 AM – 8:10 AM | Prevalence of Psychosocial Comorbidities in Vitiligo: A Systematic Literature Review | Khaled Ezzedine, MD, PhD |
| 8:10 AM – 8:20 AM | Comparative Study of Safety and Efficacy of Oral Betamethasone Pulse Therapy and Azathioprine in Vitiligo | Mahajabeen Saheb Patel Madarkar, MD |
| 8:20 AM – 8:30 AM | Effects of Adding PRP to Microneedling Plus 5-Fluorouracil Therapy in Acral Vitiligo: A Split-Body Randomized Trial | Pankhuri Dudani, MBBS |
| 8:30 AM – 8:50 AM | Vitiligo and Comorbidity: A Comprehensive Review | Invited Speaker: Jung Me Bae, MD, PhD |
| 8:50 AM – 9:00 AM | Autologous Non-cultured, Non-trypsinized Melanocyte-Keratinocyte Graft Homogenized in Plasma Gel Followed by Narrow-Band Ultraviolet B Therapy for Stable Vitiligo: A Novel Technique | Lamia Elgarhy, MD |
| 9:00 AM – 9:10 AM | Donor to Recipient Ratios in the Surgical Treatment of Vitiligo and Piebaldism: A Systematic Review | Vidhya Shankar Narayan, MD |
| 9:10 AM – 9:20 AM | Patient Stories, Data and Demo – MyVitiligoTeam (Patient Social Network) | Chris O’Brien, Senior VP My Health Teams |
| 9:20 AM – 9:40 AM | Poster Q&A Sessions #1 | Bibeau EL-Hawary Han Lee Narayan Picardo Ragab |
| 9:40 AM – 10:00 AM | Advances in Immune Mechanisms of Vitiligo | Invited Speaker: John E. Harris, MD, PhD |
| 10:00 AM – 10:10 AM | Effects of Ruxolitinib Cream on Affected Body Areas in Patients with Vitiligo: Subgroup Analysis from a 52-Week, Randomized, Double-Blind Trial | Pearl Grimes, MD |
| 10:10 AM – 10: 20 AM | Influencing Factors on the Patient Global Assessment Score for Vitiligo Severity | Nanja van Geel, MD, PhD |
| 10:20 AM – 10:30 AM | Pilot Network Model for Automated Vitiligo Lesion Segmentation: Promise and Challenges | Jesslyn Alyce Magee, MS |
| 10:30 AM – 10:50 AM | Vitiligo: Looking at the Memory T Cell Response | Invited Speaker: Julien Seneschal, MD, PhD |
| 10:50 AM – 11:10 AM | Poster Q&A Sessions #2 | Castro Porto Silva Lopes Deshpande Gandhi Karthik Krishnappa |
| 11:10 AM – 11:20 AM | Wrap up and summary of day | Davinder Parsad, MD & Iltefat Hamzavi, MD VIS 2020 Co-Chairs |
| 11:20 AM – 1:00 PM | Poster session: Attendees will go on their own to view and chat with presenters on the iPosters website. | N/A |
| Start (USA ET) | Session Title | Presenters |
|---|---|---|
| 6:00 AM – 7:00 AM | Poster session: Attendees will go on their own to view and chat with presenters on the iPosters website. | N/A |
| 7:00 AM – 7:30 AM | Virtual Waiting Room Opens | N/A |
| 7:30 AM – 7:40 AM | Welcome Back Message from Chairs | Davinder Parsad, MD & Iltefat Hamzavi, MD 2020 VIS Co-Chairs |
| 7:40 AM – 8:00 AM | International Collaborative Project to Standardize the Assessment and Monitoring of Vitiligo in Clinical Trials, Registries and Clinical Practice | Invited Speaker: Nanja van Geel, MD, PhD |
| 8:00 AM – 8:10 AM | Analysis of 24-Week Response to Ruxolitinib Cream for the Treatment of Vitiligo Based on Patient Demographics and Clinical Characteristics | Iltefat H. Hamzavi, MD, FAAD |
| 8:10 AM – 8:20 AM | An Open-Label Pilot Study of Abatacept (CTLA4-Ig) for the Treatment of Nonsegmental Vitiligo | Victor Huang, MD |
| 8:20 AM – 8:30 AM | Analysis of Matched Skin and Gut Microbiome of Vitiligo Patients Reveals Dysbiosis in Lesional Skin: Association with Mitochondrial Damage and Changes in Immune Function | Meri K. Tulic, PhD |
| 8:30 AM- 8:50 AM | Advances in Treatment of Vitiligo With Jak Inhibitors | Invited Speaker: Amit G. Pandya, MD |
| 8:50 AM – 9:00 AM | Risk Factors of Infection Post Non-cultured Melanocyte Keratinocyte Transplantation for Vitiligo | Saad Altalhab, MBBS |
| 9:00 AM – 9:10 AM | Survey Investigating the Prevalence of Vitiligo and Vitiligo Signs among Adults in Europe, Japan, and the United States | John E. Harris, MD, PhD |
| 9:10 AM – 9:20 AM | An Identification of Potential Therapeutics for Vitiligo by Mass Screening for 1,732 Medicines in Korean National Health Insurance Database | Jung Me Bae, MD, PhD |
| 9:20 AM- 9:40 AM | Poster Q&A Sessions #3 | Abdallah Bae Ghia Ju Yeon Goyal Mogawer |
| 9:40 AM – 10:00 AM | Recent Advances in the Surgical Management of Vitiligo | Invited Speaker: Davinder Parsad, MD |
| 10:00 AM – 10:10 AM | A Comparative Pilot Study of Dipstick versus Open-Spray Cryotherapy Techniques as Depigmentation Treatments for Vitiligo | Haitham M. Saleh, Msc |
| 10:10 AM – 10:20 AM | Therapeutic Response Biomarkers for Vitiligo Patients on Narrow Band Uvb and Topical Tacrolimus Combination Therapy | Youwen Zhou, MD, PhD |
| 10:20 AM – 10:30 AM | Vitiligo and Psychological Comorbidities: A Retrospective Analysis in an Urban Population | Simone Nichole Boeckmann Montgomery, BA |
| 10:30 AM – 10:50 AM | Phototherapy for Vitiligo: How to Optimize and What the Future Holds | Invited Speaker: Iltefat H. Hamzavi, MD |
| 10:50 AM – 11:10 AM | Poster Q&A Sessions #4 | Bhattacharya El-Samanoudy Mareddy Nassar Saatov Sany |
| 11:10 AM – 11:20 AM | Wrap up and summary of day | Davinder Parsad, MD & Iltefat Hamzavi, MD 2020 VIS Co-Chairs |
| 11:20 AM – 1:00 PM | Poster session: Attendees will go on their own to view and chat with presenters on the iPosters website. | N/A |